Literature DB >> 12606765

Differential effects of catalase on apoptosis induction in human promonocytic cells. Relationships with heat-shock protein expression.

Patricia Sancho1, Alfonso Troyano, Carlos Fernández, Elena De Blas, Patricio Aller.   

Abstract

The administration of the H(2)O(2)-specific scavenger catalase attenuated the generation of apoptosis by the antitumor drugs etoposide, camptothecin, doxorubicin, and cisplatin in U-937 human promonocytic cells. By contrast, the antioxidant potentiated the generation of apoptosis by the inducers of the stress response, heat shock and cadmium, in this and other myeloid cell types. Catalase also increased the heat shock-provoked stimulation of caspase-3 and -9 activities, as well as the release of cytochrome c from mitochondria to the cytosol. The potentiation of cell death by catalase correlated with its capacity to inhibit the stress response, as demonstrated by the suppression of 70- or 27-kDa heat-shock protein expression and the inhibition of heat-shock transcription factor 1 binding activity. Conversely, the toxicity of catalase plus heat shock was attenuated when the cells were preconditioned with a soft heating, which elevated the 70-kDa heat-shock protein levels. By contrast with catalase, the antioxidants superoxide dismutase and probucol did not inhibit heat-shock protein expression or affect apoptosis in U-937 cells. Finally, it was observed that the antitumor drugs did not activate the stress response in U-937 cells and that catalase failed to inhibit HSP expression and to potentiate apoptosis in heat shock-treated RPMI 8866 lymphoblastic cells. Taken together, these results provide the first demonstration of a proapoptotic action of catalase, suggest that H(2)O(2) is a critical regulator of both apoptosis and the stress response, and corroborate the antiapoptotic action of heat-shock proteins in myeloid cells.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12606765     DOI: 10.1124/mol.63.3.581

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  6 in total

1.  Anti-oxidant enzyme activities and expression and oxidative damage in patients with non-immediate reactions to drugs.

Authors:  J A Cornejo-Garcia; C Mayorga; M J Torres; T D Fernandez; R R-Pena; I Bravo; J M Mates; M Blanca
Journal:  Clin Exp Immunol       Date:  2006-08       Impact factor: 4.330

Review 2.  Human catalase: looking for complete identity.

Authors:  Madhur M Goyal; Anjan Basak
Journal:  Protein Cell       Date:  2010-11-09       Impact factor: 14.870

3.  Iron alters cell survival in a mitochondria-dependent pathway in ovarian cancer cells.

Authors:  Kyle Bauckman; Edward Haller; Nicholas Taran; Stephanie Rockfield; Abigail Ruiz-Rivera; Meera Nanjundan
Journal:  Biochem J       Date:  2015-03-01       Impact factor: 3.857

4.  Ethanol Enhances Hyperthermia-Induced Cell Death in Human Leukemia Cells.

Authors:  Mercedes Quintana; Ester Saavedra; Henoc Del Rosario; Ignacio González; Inmaculada Hernández; Francisco Estévez; José Quintana
Journal:  Int J Mol Sci       Date:  2021-05-06       Impact factor: 5.923

5.  Cell survival from chemotherapy depends on NF-kappaB transcriptional up-regulation of coenzyme Q biosynthesis.

Authors:  Gloria Brea-Calvo; Emilio Siendones; José A Sánchez-Alcázar; Rafael de Cabo; Plácido Navas
Journal:  PLoS One       Date:  2009-04-23       Impact factor: 3.240

Review 6.  Recent Advances in Genetic and Epigenetic Modulation of Animal Exposure to High Temperature.

Authors:  Jiong Wu; Weiwei Zhang; Chenghua Li
Journal:  Front Genet       Date:  2020-07-07       Impact factor: 4.599

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.